Literature DB >> 29297110

Subtyping Schizophrenia by Social Functioning - a Pragmatic Proposal for Clinics and Research.

Takefumi Suzuki1.   

Abstract

Schizophrenia has been claimed to be a "heterogeneous" disorder despite the fact that a diagnosis is made without reliable biomarkers but sorely with a constellation of "common" observable symptoms that however may be overlooked. Alternatively functional impairments are the prerequisite to make a diagnosis and may be simpler and more pragmatic to express objectively. It would then be reasonable to categorize patients according to the magnitude of psychosocial impairments, as has been done in terms of the severity of "classical" symptoms. In this context the author proposes a new paradigm in which patients with schizophrenia are classified into three functional subtypes using the anchors for the Clinical Global Impression Functioning subscale (CGI-F, adopted from the CGI) and the Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz): Class 1 patients are those with no to mild functional impairments (a score of 1-3 in the CGI-F and a score of 60-100 in the FACT-Sz), Class 2 patients are those with moderate to marked impairments (4 or 5 in the CGI-F and 40-59 in the FACT-Sz), and Class 3 patients are those with severe to most severe impairments (6 or 7 in the CGI-F 6,7 and 0-39 in the FACT-Sz). The author has no intention to ignore the importance of other domains of the illness but instead provides a simple framework as what the patient is actually doing is considered to represent the proximal "hard outcome" and certainly has the relevance in the management of schizophrenia. Implications of this pragmatic classification system for clinics and research are discussed.

Entities:  

Keywords:  Functioning; Rating scale; Schizophrenia; Subtype

Mesh:

Year:  2018        PMID: 29297110     DOI: 10.1007/s11126-017-9558-z

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  11 in total

1.  What is a'mood-congruent' delusion? History and conceptual problems.

Authors:  Tsutomu Kumazaki
Journal:  Hist Psychiatry       Date:  2011-09

2.  Magnitude of rater differences in assessment scales for schizophrenia.

Authors:  Takefumi Suzuki; Hiroyoshi Takeuchi; Shinichiro Nakajima; Kensuke Nomura; Hiroyuki Uchida; Gohei Yagi; Koichiro Watanabe; Haruo Kashima
Journal:  J Clin Psychopharmacol       Date:  2010-10       Impact factor: 3.153

3.  Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Kensuke Nomura; Hiroyoshi Takeuchi; Shinichiro Nakajima; Akira Tanabe; Gohei Yagi; Koichiro Watanabe; Haruo Kashima
Journal:  Schizophr Res       Date:  2008-09-19       Impact factor: 4.939

Review 4.  Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Hitoshi Sakurai; Tomomi Ishizuki; Kenichi Tsunoda; Hiroyoshi Takeuchi; Masaru Mimura
Journal:  Psychiatry Res       Date:  2015-04-01       Impact factor: 3.222

5.  Catamnestic long-term study on the course of life and aging of schizophrenics.

Authors:  L Ciompi
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

Review 6.  Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review.

Authors:  Takefumi Suzuki
Journal:  Psychopharmacol Bull       Date:  2011

Review 7.  A review on schizophrenia and relapse--a quest for user-friendly psychopharmacotherapy.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Hiroyoshi Takeuchi; Takashi Tsuboi; Jinichi Hirano; Masaru Mimura
Journal:  Hum Psychopharmacol       Date:  2014-09       Impact factor: 1.672

8.  Five factor model of schizophrenia: replication across samples.

Authors:  J P Lindenmayer; S Grochowski; R B Hyman
Journal:  Schizophr Res       Date:  1995-02       Impact factor: 4.939

Review 9.  Treatment target in schizophrenia: a critical review and a clinical suggestion.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2008

10.  Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia.

Authors:  W S Fenton; T H McGlashan
Journal:  Arch Gen Psychiatry       Date:  1991-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.